Perficient Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Perficient Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-06-30 | 2005-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 17,438,000 | 11,555,000 | 23,175,000 | 22,596,000 | 26,362,000 | 26,800,000 | 26,459,000 | 23,015,000 | 27,782,000 | 27,136,000 | 4,529,000 | 17,396,000 | 16,573,000 | 13,593,000 | 8,421,000 | 6,177,000 | 6,609,000 | 8,974,000 | 11,792,000 | 9,779,000 | 8,528,000 | 7,026,000 | 7,476,000 | 6,305,000 | 6,655,000 | 4,123,000 | 4,376,000 | 5,142,000 | 3,603,000 | 2,986,000 | 2,721,000 | 3,466,000 | 2,767,000 | 1,793,000 | 1,307,000 | 2,254,000 | 2,051,000 | 868,000 | 629,000 | 115,000 | -196,000 | 915,000 | 759,000 | 2,176,000 | 3,989,000 | 3,076,000 | 4,515,000 | 4,541,000 | 4,014,000 | 3,160,000 | 2,774,000 | 2,833,344 | 2,255,013 | 1,704,643 | 1,626,811 | 1,488,303 |
adjustments to reconcile net income to net cash from operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 1,840,000 | 2,011,000 | 2,245,000 | 2,194,000 | 2,224,000 | 2,305,000 | 2,285,000 | 2,355,000 | 2,005,000 | 1,873,000 | 1,716,000 | 1,607,000 | 1,615,000 | 1,460,000 | 1,437,000 | 1,388,000 | 1,317,000 | 1,288,000 | 1,266,000 | 1,095,000 | 1,070,000 | 1,016,000 | 1,015,000 | 995,000 | 1,379,000 | 683,000 | 661,000 | 612,000 | 515,000 | 463,000 | 547,000 | 484,000 | 398,000 | 325,000 | 263,000 | 225,000 | 195,000 | 147,000 | 240,000 | 375,000 | 393,000 | 475,000 | 510,000 | 535,000 | 556,000 | 538,000 | 484,000 | 371,000 | 361,000 | 337,000 | 301,000 | 263,890 | 215,393 | 167,717 | 132,885 | 177,336 |
amortization | 4,862,000 | 4,886,000 | 4,260,000 | 5,032,000 | 5,523,000 | 5,817,000 | 6,454,000 | 6,087,000 | 5,998,000 | 5,979,000 | 5,751,000 | 4,317,000 | 6,333,000 | 7,052,000 | 7,300,000 | 7,237,000 | 4,398,000 | 3,922,000 | 4,007,000 | 3,997,000 | 4,010,000 | 4,137,000 | 4,327,000 | 4,009,000 | 6,243,000 | 1,777,000 | 2,163,000 | 2,258,000 | 1,841,000 | 1,565,000 | 1,678,000 | 1,984,000 | 1,536,000 | 1,143,000 | 965,000 | 975,000 | 1,072,000 | 942,000 | 1,028,000 | 1,022,000 | 1,106,000 | 1,111,000 | 1,187,000 | |||||||||||||
deferred income taxes | -7,355,000 | -796,000 | -6,054,000 | 2,652,000 | -5,663,000 | -1,885,000 | -592,000 | -6,964,000 | -4,476,000 | 4,087,000 | -11,404,000 | -295,000 | -1,418,000 | 455,000 | -152,000 | -1,688,000 | -1,356,000 | 1,608,000 | 43,000 | -75,000 | 79,000 | 1,994,000 | 723,000 | -119,000 | 192,000 | 582,000 | -856,000 | 220,000 | -676,000 | 699,000 | -720,000 | 1,127,000 | -410,000 | 534,000 | 365,000 | 110,000 | -502,000 | 232,000 | -201,000 | -78,000 | -298,000 | 559,000 | 836,000 | -2,154,000 | -259,000 | -192,000 | -1,390,000 | 471,000 | ||||||||
non-cash stock compensation and retirement savings plan contributions | 5,907,000 | 12,222,000 | 7,154,000 | 6,745,000 | 7,155,000 | 6,674,000 | 6,335,000 | 6,047,000 | 5,980,000 | 5,706,000 | 5,546,000 | 5,688,000 | 5,207,000 | 5,113,000 | 4,986,000 | 4,688,000 | 4,865,000 | 4,607,000 | 4,973,000 | 4,096,000 | 4,108,000 | 4,248,000 | 4,171,000 | 3,945,000 | 5,007,000 | 2,608,000 | 2,595,000 | 2,547,000 | 2,242,000 | 2,206,000 | 2,418,000 | 2,427,000 | 2,276,000 | 2,057,000 | 3,301,000 | 2,483,000 | 2,571,000 | 2,476,000 | 2,429,000 | 2,509,000 | 2,447,000 | 2,451,000 | 2,181,000 | 2,217,000 | 2,267,000 | 2,280,000 | ||||||||||
amortization of debt issuance costs | 632,000 | 631,000 | 631,000 | 631,000 | 608,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to fair value of contingent consideration for purchase of businesses | 67,000 | 41,000 | -1,748,000 | -2,701,000 | -2,026,000 | 3,115,000 | -2,487,000 | -979,000 | 42,000 | -510,000 | 514,000 | 2,061,000 | ||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of business acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -24,593,000 | 10,928,000 | 6,222,000 | 1,220,000 | -2,616,000 | 18,784,000 | -4,182,000 | 5,816,000 | -10,025,000 | -8,433,000 | -4,296,000 | -13,789,000 | -10,713,000 | -5,653,000 | 4,855,000 | -10,252,000 | 5,978,000 | 7,656,000 | -2,794,000 | -3,555,000 | -4,346,000 | 7,293,000 | -11,698,000 | -143,000 | 13,338,000 | -1,742,000 | 8,343,000 | -1,358,000 | -6,027,000 | -1,776,000 | -1,339,000 | -1,787,000 | 3,574,000 | 482,000 | 489,000 | -2,420,000 | -140,000 | -4,454,067 | -157,783 | -3,213,785 | 2,484,322 | |||||||||||||||
other assets | -13,381,000 | -1,360,000 | 8,604,000 | -6,469,000 | -6,766,000 | 5,705,000 | -5,273,000 | 1,294,000 | -1,905,000 | -1,542,000 | -2,551,000 | 4,447,000 | -2,306,000 | -3,065,000 | 742,000 | -1,087,000 | 1,687,000 | 479,000 | -971,000 | 1,274,000 | -2,522,000 | -5,458,000 | -3,559,000 | -265,000 | 3,284,000 | -1,862,000 | -436,000 | -4,000 | 872,000 | 642,000 | 2,059,000 | -1,256,000 | -448,000 | -675,000 | 1,038,000 | -301,000 | 648,000 | 241,000 | 647,000 | -1,388,000 | 370,000 | 29,000 | 734,000 | 1,295,000 | -2,509,000 | 834,000 | 3,179,000 | -2,918,000 | 1,352,000 | 1,643,000 | 1,391,076 | 324,491 | 76,513 | -433,296 | ||
accounts payable | 1,162,000 | -4,824,000 | 3,337,000 | -892,000 | 1,685,000 | -9,909,000 | 4,551,000 | -1,311,000 | -1,682,000 | -4,295,000 | 4,886,000 | -7,003,000 | 10,017,000 | -7,844,000 | 8,233,000 | -376,000 | 587,000 | -7,583,000 | 8,608,000 | -682,000 | 2,494,000 | -11,776,000 | 13,635,000 | -3,693,000 | -7,272,000 | -1,429,000 | 422,000 | 2,528,000 | 109,000 | -869,000 | 1,010,000 | 317,000 | 273,000 | -3,122,000 | 26,000 | 1,284,000 | -230,000 | -438,000 | -262,000 | 1,097,000 | -1,315,000 | -404,000 | 1,733,000 | -973,000 | 433,000 | -794,000 | 641,000 | -217,000 | -327,000 | -1,791,000 | 92,519 | -1,122,707 | -1,050,891 | -4,261,345 | ||
other liabilities | 10,702,000 | -3,323,000 | 4,872,000 | -8,588,000 | -2,054,000 | -11,542,000 | 9,736,000 | -2,600,000 | 1,009,000 | -18,966,000 | 10,376,000 | -6,999,000 | 1,359,000 | -12,992,000 | 14,083,000 | 7,705,000 | 14,517,000 | -26,201,000 | 11,556,000 | -3,225,000 | 9,460,000 | -9,548,000 | 8,504,000 | 1,238,000 | -72,000 | -5,031,000 | 1,292,000 | -347,000 | 5,184,000 | -3,982,000 | 561,000 | -1,511,000 | 3,624,000 | -7,224,000 | -1,123,000 | -609,000 | 4,764,000 | -1,843,000 | 1,897,000 | -994,000 | 1,269,000 | -4,258,000 | 2,368,000 | -1,667,000 | 2,352,000 | -5,877,000 | 1,633,000 | -1,953,000 | 3,491,000 | -8,297,000 | 42,030 | -2,776,896 | 1,530,690 | -1,473,435 | ||
net cash from operating activities | -2,719,000 | 31,971,000 | 54,483,000 | 23,373,000 | 23,780,000 | 41,331,000 | 46,627,000 | 37,461,000 | 22,806,000 | 11,174,000 | 46,781,000 | 8,255,000 | 28,719,000 | 1,161,000 | 58,341,000 | 22,119,000 | 41,884,000 | -4,384,000 | 40,278,000 | 13,875,000 | 24,157,000 | -345,000 | 25,788,000 | 13,238,000 | 30,072,000 | -518,000 | 18,362,000 | 11,376,000 | 7,610,000 | 1,863,000 | 12,447,000 | 5,998,000 | 2,746,000 | -6,871,000 | 3,948,000 | 5,068,000 | 5,085,000 | 4,630,000 | 4,789,000 | 1,928,000 | 11,060,000 | 4,786,000 | 14,008,000 | 1,848,000 | 6,256,000 | 4,656,000 | 12,893,000 | 3,522,000 | 8,370,000 | -1,734,000 | 7,116,000 | 1,986,266 | 1,219,707 | -706,973 | -528,956 | -1,673,212 |
capex | -2,580,000 | -660,000 | -327,000 | -1,258,000 | -2,464,000 | -1,343,000 | -2,202,000 | -1,036,000 | -4,014,000 | -2,647,000 | -3,550,000 | -2,462,000 | -2,364,000 | -1,828,000 | -1,606,000 | -1,584,000 | -1,517,000 | -1,703,000 | -1,923,000 | -3,370,000 | -2,516,000 | -1,447,000 | -989,000 | -1,805,000 | 699,000 | -2,484,000 | -612,000 | -585,000 | -516,000 | -397,000 | -451,000 | -722,000 | -1,127,000 | -655,000 | -381,000 | -365,000 | -375,000 | -200,000 | -102,000 | -144,000 | -119,000 | -145,000 | -292,000 | -267,000 | -511,000 | -435,000 | -752,000 | -585,000 | -423,000 | -456,000 | 0 | 0 | -420,164 | -325,152 | -163,288 | -171,712 |
free cash flows | -5,299,000 | 31,311,000 | 54,156,000 | 22,115,000 | 21,316,000 | 39,988,000 | 44,425,000 | 36,425,000 | 18,792,000 | 8,527,000 | 43,231,000 | 5,793,000 | 26,355,000 | -667,000 | 56,735,000 | 20,535,000 | 40,367,000 | -6,087,000 | 38,355,000 | 10,505,000 | 21,641,000 | -1,792,000 | 24,799,000 | 11,433,000 | 30,771,000 | -3,002,000 | 17,750,000 | 10,791,000 | 7,094,000 | 1,466,000 | 11,996,000 | 5,276,000 | 1,619,000 | -7,526,000 | 3,567,000 | 4,703,000 | 4,710,000 | 4,430,000 | 4,687,000 | 1,784,000 | 10,941,000 | 4,641,000 | 13,716,000 | 1,581,000 | 5,745,000 | 4,221,000 | 12,141,000 | 2,937,000 | 7,947,000 | -2,190,000 | 7,116,000 | 1,986,266 | 799,543 | -1,032,125 | -692,244 | -1,844,924 |
investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment | -2,249,000 | -319,000 | -230,000 | -1,009,000 | -2,185,000 | -1,015,000 | -1,936,000 | -779,000 | -3,768,000 | -2,472,000 | -3,352,000 | -2,269,000 | -2,143,000 | -1,480,000 | -1,386,000 | -1,433,000 | -934,000 | -1,513,000 | -1,616,000 | -3,026,000 | -2,128,000 | -1,312,000 | -902,000 | -1,618,000 | 699,000 | -2,263,000 | -532,000 | -547,000 | -489,000 | -355,000 | -383,000 | -665,000 | -1,098,000 | -630,000 | -345,000 | -322,000 | -340,000 | -154,000 | -102,000 | -144,000 | -77,000 | -92,000 | -237,000 | -206,000 | -447,000 | -430,000 | -703,000 | -525,000 | -401,000 | -406,000 | -420,164 | -277,563 | -163,288 | -171,712 | ||
capitalization of internally developed software costs | -331,000 | -341,000 | -97,000 | -249,000 | -279,000 | -328,000 | -266,000 | -257,000 | -246,000 | -175,000 | -198,000 | -193,000 | -221,000 | -348,000 | -220,000 | -165,000 | -583,000 | -497,000 | -307,000 | -344,000 | -388,000 | -135,000 | -87,000 | -187,000 | ||||||||||||||||||||||||||||||||
purchase of businesses, net of cash acquired | 217,000 | -33,157,000 | -443,000 | 0 | 226,000 | 28,000 | -27,135,000 | -44,649,000 | 0 | -67,000 | -93,976,000 | -14,860,000 | -1,693,000 | 1,011,000 | -5,862,000 | -7,260,000 | -7,814,000 | -5,838,000 | ||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -2,363,000 | -33,817,000 | -770,000 | -1,258,000 | -2,238,000 | -1,315,000 | -29,337,000 | -45,685,000 | -4,014,000 | -2,714,000 | -97,526,000 | -17,322,000 | -2,376,000 | -1,828,000 | -3,299,000 | -587,000 | -62,933,000 | -31,795,000 | -1,923,000 | -3,850,000 | -12,827,000 | -1,799,000 | -6,416,000 | -11,740,000 | -10,171,000 | -2,961,000 | -760,000 | -11,289,000 | -11,798,000 | -14,823,000 | -816,000 | -12,982,000 | 3,770,000 | 1,243,000 | -2,880,000 | 812,000 | -3,871,000 | -4,575,000 | -5,920,000 | -4,512,000 | -120,000 | -158,000 | -802,000 | -301,000 | -700,000 | -538,000 | -6,614,000 | -7,845,000 | -8,237,000 | -6,294,000 | -8,050,092 | -325,152 | -5,192,929 | -171,712 | ||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for credit facility financing fees | 0 | 0 | -67,000 | -683,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration for purchase of business | 0 | -4,516,000 | 0 | 0 | 0 | -21,530,000 | -17,658,000 | -2,262,000 | -1,944,000 | 0 | 0 | -131,000 | -129,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of stock through the employee stock purchase plan | 287,000 | 197,000 | 210,000 | 247,000 | 278,000 | 240,000 | 249,000 | 257,000 | 293,000 | 282,000 | 268,000 | 152,000 | 106,000 | 105,000 | 100,000 | 94,000 | 76,000 | 40,000 | 45,000 | 41,000 | 44,000 | 43,000 | ||||||||||||||||||||||||||||||||||
purchases of treasury stock | -3,747,000 | -2,610,000 | -2,596,000 | -2,395,000 | -5,410,000 | -9,234,000 | -3,818,000 | -6,104,000 | -6,894,000 | -4,908,000 | -8,461,000 | -835,000 | -3,517,000 | -4,825,000 | -11,435,000 | -12,632,000 | -41,577,000 | -4,393,000 | ||||||||||||||||||||||||||||||||||||||
remittance of taxes withheld as part of a net share settlement of restricted stock vesting | -4,000 | -4,269,000 | -1,909,000 | -30,000 | -23,000 | -5,054,000 | -2,655,000 | 0 | -19,000 | -8,988,000 | -8,220,000 | 0 | -9,000 | -5,234,000 | -3,167,000 | 0 | -26,000 | -4,835,000 | -3,354,000 | -17,000 | -40,000 | -3,925,000 | -2,153,000 | -13,000 | -2,575,000 | -320,000 | -1,275,000 | -49,000 | -321,000 | -212,000 | ||||||||||||||||||||||||||
net cash from financing activities | 283,000 | -8,588,000 | -5,446,000 | -2,393,000 | -2,408,000 | -29,422,000 | -7,851,000 | -8,977,000 | -3,544,000 | -8,706,000 | 18,946,000 | -21,110,000 | -11,638,000 | -10,037,000 | -22,727,000 | 8,872,000 | 11,174,000 | -4,795,000 | -4,141,000 | -7,770,000 | -4,824,000 | -15,316,000 | -19,289,000 | 1,796,000 | -15,271,000 | -839,000 | 5,768,000 | 5,874,000 | -3,873,000 | -3,562,000 | -3,443,000 | 2,340,000 | -2,244,000 | -6,696,000 | -4,053,000 | -559,000 | -5,206,000 | -4,382,000 | -4,541,000 | -2,663,000 | -5,842,000 | -4,268,000 | -181,000 | 693,000 | 1,413,000 | 4,202,000 | -645,000 | 4,484,000 | -2,023,000 | 3,100,259 | 6,092,431 | -1,718,690 | 3,798,919 | 1,917,302 | ||
effect of exchange rate on cash, cash equivalents and restricted cash | -457,000 | -259,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in cash, cash equivalents and restricted cash | -5,256,000 | -10,693,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 128,886,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | -5,256,000 | 118,193,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 28,746,000 | 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs and discounts | 1,135,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to fair value of contingent consideration for purchase of business | -335,000 | 611,000 | -2,000 | 116,000 | -424,000 | 59,000 | 666,000 | 82,000 | 97,000 | 167,000 | 171,000 | -60,000 | 11,000 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||
other | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of convertible notes | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for convertible notes issuance costs | -509,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of hedges related to issuance of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of warrants related to issuance of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for repurchase of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of hedges related to repurchase of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of warrants related to repurchase of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from line of credit | 59,000,000 | 0 | 8,000,000 | 0 | 43,500,000 | 95,650,000 | 21,850,000 | 18,800,000 | 48,700,000 | 41,400,000 | 26,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
payments on line of credit | -59,000,000 | 0 | -20,000,000 | 0 | -99,500,000 | -97,850,000 | -18,650,000 | -27,500,000 | -49,700,000 | -35,100,000 | -19,800,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | 8,796,000 | 1,218,000 | 1,474,000 | 2,194,000 | 1,191,000 | 397,000 | 2,605,000 | 436,000 | 1,046,000 | 574,000 | 3,616,000 | 1,927,000 | 3,351,000 | 793,000 | 2,119,000 | 1,654,000 | 2,599,000 | 1,438,000 | 1,340,000 | 1,519,000 | 1,186,000 | 220,000 | 397,000 | 100,000 | 1,083,000 | 251,000 | 1,324,000 | 4,347,000 | 3,706,000 | 829,000 | 230,000 | 3,032,000 | 241,000 | 177,000 | 45,000 | 1,538,552 | 1,357,793 | 214,655 | 777,355 | 92,220 | ||||||||||||||||
cash paid for interest | 10,000 | 1,445,000 | 90,000 | 1,508,000 | 54,000 | 1,759,000 | 47,000 | 1,797,000 | 803,000 | 3,000 | 2,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
non-cash activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for purchase of businesses | 0 | 0 | -222,000 | 88,000 | 2,077,000 | 10,602,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of shares for repurchase of convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liability incurred for purchase of property and equipment | 14,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate on cash and cash equivalents | -106,000 | 342,000 | 271,000 | -154,000 | -822,000 | -555,000 | 11,000 | -196,000 | -104,000 | -77,000 | -442,000 | 857,000 | 84,000 | 118,000 | -453,000 | 94,000 | -117,000 | 42,000 | 210,000 | -46,000 | -164,000 | -342,000 | 18,000 | 1,000 | 0 | -1,000 | 8,000 | 15,000 | 11,000 | 11,000 | -9,000 | 22,000 | 43,000 | 1,000 | 1,000 | 3,000 | -2,000 | -8,000 | 0 | 12,000 | 6,000 | 33,000 | -11,000 | -7,000 | -9,000 | |||||||||||
change in cash and cash equivalents | 19,616,000 | 19,476,000 | 10,865,000 | 9,285,000 | -18,023,000 | 14,693,000 | -235,000 | -31,995,000 | -30,281,000 | 14,628,000 | -11,146,000 | 33,172,000 | 30,488,000 | -9,757,000 | -41,427,000 | 34,308,000 | 2,138,000 | 6,548,000 | -17,250,000 | 37,000 | 34,588,000 | 5,717,000 | -1,665,000 | 2,332,000 | -752,000 | 1,579,000 | -7,078,000 | 7,773,000 | -10,535,000 | 3,084,000 | -3,297,000 | -1,154,000 | -773,000 | -2,838,000 | -503,000 | -6,337,000 | -6,962,000 | 6,402,000 | 1,963,000 | 7,356,000 | -2,721,000 | 5,387,000 | 4,817,000 | 7,725,000 | -132,000 | -519,000 | -3,553,000 | 53,272 | ||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 30,130,000 | 0 | 0 | 0 | 24,410,000 | 0 | 0 | 0 | 83,204,000 | 0 | 0 | 0 | 70,728,000 | 0 | 0 | 0 | 44,984,000 | 0 | 0 | 494,000 | 5,813,000 | 0 | 0 | 0 | 9,732,000 | 0 | 0 | 0 | 12,707,000 | 0 | 0 | 0 | 17,975,000 | 0 | 0 | 0 | 22,909,000 | 0 | 0 | 0 | 8,070,000 | 0 | 0 | 0 | 4,549,000 | 0 | -409 | 0 | 5,096,409 | 0 | 3,905,460 | |||
cash and cash equivalents at end of period | 19,616,000 | 19,476,000 | 40,995,000 | 9,285,000 | -18,023,000 | 14,693,000 | 24,175,000 | -31,995,000 | -30,281,000 | 14,628,000 | 72,058,000 | 33,172,000 | 30,488,000 | -9,757,000 | 29,301,000 | 34,308,000 | 2,138,000 | 6,548,000 | 27,734,000 | 37,000 | 34,588,000 | 6,211,000 | 4,148,000 | 2,332,000 | -752,000 | 1,579,000 | 2,654,000 | 7,773,000 | -10,535,000 | 3,084,000 | 9,410,000 | -1,154,000 | -773,000 | -2,838,000 | 17,472,000 | -6,337,000 | -6,962,000 | 6,402,000 | 24,872,000 | 7,356,000 | -2,721,000 | 5,387,000 | 12,887,000 | 7,725,000 | -132,000 | -519,000 | 996,000 | 4,484,000 | -1,530,470 | -741,320 | 2,336,790 | -1,929,221 | 3,958,732 | |||
amortization of debt discount and issuance costs | 607,000 | 607,000 | 608,000 | 2,594,000 | 2,562,000 | 2,528,000 | 1,929,000 | 1,215,000 | 1,201,000 | 1,173,000 | 1,160,000 | 1,147,000 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of 2025 convertible notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for 2025 convertible notes issuance costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of 2025 convertible notes hedges | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of 2025 convertible notes warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for repurchase of 2023 convertible notes | -9,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of of hedges related to 2023 convertible notes | 2,724,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of warrants related to 2023 convertible notes | -2,329,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash investing activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of convertible notes hedges | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of convertible notes warrants | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock surrendered by sellers in conjunction with net working capital settlement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liability incurred for purchase of property, plant and equipment | 307,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of businesses | -29,785,000 | -365,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for purchase of business | 4,239,000 | 3,159,000 | 6,270,000 | 6,143,000 | 0 | 0 | 1,103,000 | 5,755,000 | 5,160,153 | |||||||||||||||||||||||||||||||||||||||||||||||
write-off unamortized credit facility fees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for credit facility financing fees | 0 | -7,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options and sales of stock through the employee stock purchase plan | 43,000 | 68,000 | 73,000 | 31,000 | 30,000 | 107,000 | 116,000 | 83,000 | 3,406,000 | 443,000 | 260,000 | 599,000 | 166,000 | |||||||||||||||||||||||||||||||||||||||||||
purchase of business | -10,311,000 | -352,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of short-term investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of short-term investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from settlement of company-owned life insurance | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments to fund company-owned life insurance | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of unamortized credit facility fees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in ) provided by financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit from stock option exercises and restricted stock vesting | -227,000 | -280,000 | -319,000 | -220,000 | -242,000 | -284,000 | -35,000 | -216,000 | -1,303,000 | -602,000 | -347,000 | -298,000 | -284,000 | |||||||||||||||||||||||||||||||||||||||||||
capitalization of software developed for internal use | -221,000 | -80,000 | -38,000 | -27,000 | -42,000 | -68,000 | -57,000 | -29,000 | -25,000 | -36,000 | -43,000 | -35,000 | -46,000 | -42,000 | -53,000 | -55,000 | -61,000 | -64,000 | -5,000 | -49,000 | -60,000 | -22,000 | -50,000 | -47,589 | ||||||||||||||||||||||||||||||||
purchase of business and related costs | -477,000 | -10,704,000 | -11,282,000 | -14,426,000 | -289,000 | 0 | -1,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit on stock option exercises and restricted stock vesting | 227,000 | 319,000 | 220,000 | 242,000 | 35,000 | 216,000 | 1,303,000 | 347,000 | 298,000 | 284,000 | ||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock | -1,354,000 | -53,000 | -166,000 | -386,000 | -3,712,000 | -3,444,000 | -2,369,000 | -7,303,000 | -4,950,000 | -1,009,000 | -5,750,000 | -4,234,000 | -2,758,000 | |||||||||||||||||||||||||||||||||||||||||||
non-cash activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturity of investments | 2,187,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments | 657,000 | 1,462,000 | -3,496,000 | -2,875,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for settlement of contingent consideration for purchase of business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
estimated fair value of contingent consideration for purchase of business | 97,000 | 171,000 | 152,000 | 708,000 | 13,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
payment of credit facility financing fees | -1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
estimated initial fair value of contingent consideration for purchase of business | 3,399,000 | 2,647,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts and note receivable | -339,000 | -1,603,000 | -1,021,000 | -5,156,000 | 2,289,000 | -1,510,000 | -255,000 | 7,284,000 | 3,908,000 | 2,067,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales and maturity of investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from short-term borrowings | 0 | 0 | 0 | 2,800,000 | 9,100,000 | 4,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
payments on short-term borrowings | 0 | 0 | 0 | -4,700,000 | -7,200,000 | -3,000,000 | 0 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to fair value of contingent consideration | 334,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale and maturity of investments | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisitions and related costs | -510,000 | -34,000 | -189,000 | -103,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on long-term debt | 0 | 0 | -988,000 | -350,000 | -331,397 | -325,637 | -308,927 | -191,991 | ||||||||||||||||||||||||||||||||||||||||||||||||
capitalization of internally developed software | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for certain acquisition related costs | -1,000 | -13,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options and purchases of stock under the employee stock purchase plan | 393,000 | 72,000 | 216,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non cash activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit (expense) on stock option exercises and restricted stock vesting | -379,000 | -121,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense | 0 | -153 | 1,552 | 4,601 | 5,903 | 8,870 | ||||||||||||||||||||||||||||||||||||||||||||||||||
payments on javelin notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit (expense) of stock option exercises and restricted stock vesting | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options and employee stock purchase plan | 47,000 | 189,000 | 270,000 | 417,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in goodwill | 490,000 | 0 | 0 | 2,000 | -1,687,000 | -1,000 | -12,000 | -257,000 | -215,000 | -43,562 | 571,131 | 90,000 | ||||||||||||||||||||||||||||||||||||||||||||
write-off of deferred offering costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit on stock options and restricted stock vesting | 336,000 | -38,000 | 276,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
non cash activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of intangibles | 1,214,000 | 1,217,000 | 1,609,000 | 1,277,000 | 980,000 | 846,000 | 1,123,000 | 1,211,452 | 698,657 | 424,891 | 303,763 | 276,876 | ||||||||||||||||||||||||||||||||||||||||||||
non-cash stock compensation | 1,740,000 | 1,461,000 | 1,423,000 | 1,580,000 | 905,000 | 757,482 | 745,448 | 724,070 | 59,155 | 59,157 | ||||||||||||||||||||||||||||||||||||||||||||||
tax benefit on stock options | 3,116,000 | 1,336,000 | 1,702,000 | 219,914 | -662,833 | 894,919 | ||||||||||||||||||||||||||||||||||||||||||||||||||
deferred offering costs | -226,472 | -565,698 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options and employee stock purchase plan | 1,086,000 | 907,000 | 1,232,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of warrants | 99,599 | 1 | 46,400 | 0 | 107,143 | |||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 14,000 | 26,000 | 75,000 | 250,018 | 103,985 | 110,997 | 104,327 | 87,221 | ||||||||||||||||||||||||||||||||||||||||||||||||
change in deferred income taxes | 928,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit on stock option exercises | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from revolving line of credit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on revolving line of credit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from stock issuances | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock and options issued in purchase of businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on long-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | 971,717 | 646,734 | 334,318 | 567,848 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from stock sales under the employee stock purchase plan | 14,443 | 18,894 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate on cash | -8,804 | -6,255 | -19,106 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
change in cash | -2,759,619 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
reduction in goodwill as a result of changes in estimated acquisition costs | 61,498 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangibles amortization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
bad debt expense, net of recoveries | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additions to software developed for internal use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposal of assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on capital lease obligation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock issuance costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
forfeiture of merger consideration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reduction of goodwill as a result of utilization of net tax operating incomees from acquisitions which had previously been fully reserved, forfeiture of restricted stock used for acquisition purchase consideration and changes in estimated acquisition transaction costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred stock compensation from issuance of restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit of stock option exercises | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for purchases of businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit of non-qualified stock option exercises | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment on javelin notes |
We provide you with 20 years of cash flow statements for Perficient stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Perficient stock. Explore the full financial landscape of Perficient stock with our expertly curated income statements.
The information provided in this report about Perficient stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.